Back to results
US 2013/0274128 A1Published application
Gene expression in n-cadherin overexpressing prostate cancers and their controls
AssigneeThe Regents of the University of Califorina
InventorRobert E. Reiter
Life of this patent
Estimating the term…
Abstract
The present invention provides methods of diagnosing a cancer or providing a prognosis for a cancer by analyzing the level of expression of a marker that is a downstream target of N-cadherin.
Claims30
A method of diagnosing a cancer in a subject, the method comprising the steps of:
- (a) analyzing a tissue sample from the subject with an assay that specifically detects at least one marker that is a downstream target of N-cadherin, wherein the at least one marker is selected from the markers listed in Table 3 or Table 4;
- and
- (b) determining whether or not expression of the at least one marker is altered in the tissue sample;
- thereby providing a diagnosis for the cancer.
1 more element
A method of providing a prognosis for a cancer in a subject, the method comprising the steps of:
- (a) analyzing a tissue sample from the subject with an assay that specifically detects at least one marker that is a downstream target of N-cadherin, wherein the at least one marker is selected from the markers listed in Table 3 or Table 4;
- and
- (b) determining whether or not expression of the at least one marker is altered in the tissue sample;
- thereby providing a prognosis for the cancer.
1 more element
Dependencies are inferred from the claim text.